Today's Date: June 12, 2024
Pro Football Hall of Fame, Coordinated Care, Seattle Seahawks and Other Local Partners Host 'Strong Youth Strong Communities' Su   •   Church of the Highlands Hosted Their Annual Impact Golf Tournament to Benefit Local Organizations   •   THE JIM HENSON COMPANY IS TEAMING UP WITH THE OPERATING ROOM TO DEVELOP CG ANIMATED SERIES, ADRENALINE LEMMINGS   •   Sharp Launches New 4K UHD Projectors   •   Church of the Highlands to Host “Cokes on the Lawn” After Monthly First Wednesday Service   •   Nicklaus Children's Awarded Gold Level from the American Heart Association for Promoting Healthy Work Culture   •   Sandbox VR Opens First Florida Location June 27 in the Grand Central District   •   University of Louisville Study Outlines Humana’s Economic and Community Impact on Kentucky   •   “Golden Eight” Collection of Signed Michael Phelps Paintings Unveiled for the First Time Ahead of 2024 Summer Olympi   •   United Teams Up with Chicago Bears to Support Special Olympics   •   Statement by The National Council for Incarcerated and Formerly Incarcerated Women and Girls on Hunter Biden's Conviction   •   House Speaker to Host 3rd Annual Juneteenth Celebration   •   Minister Sudds provides an update on Canada's progress on the 2030 Agenda for Sustainable Development   •   The Benefits Are On The Balance Sheet: Corporate America Must Stand By DEI And Chief Diversity Officers   •   Church of the Highlands to Host Their Annual 3-Day Children’s Conference on June 24 - 26   •   Matthew Carnes, S.J., Named Vice President for Mission and Ministry at Santa Clara University   •   Church of the Highlands to Host “Summer at Highlands,” A Series of Summer Events and Conferences   •   Driving Decarbonization in America - To Air on MotorTrend TV, Discovery Go and Discovery+ Streaming   •   GREEN BAY INTEGRATIVE HEALTH LAUNCHES CUTTING-EDGE PROCEDURES FOR TIGHTENING/TONING MUSCLES WITHOUT PAIN OR DOWNTIME   •   Reading Horizons Discovery® Earns Prestigious ‘All-Green’ Rating from EdReports
Bookmark and Share

Slone Partners Places Kevin Eastwood as Chief Business Officer at Arpeggio Biosciences

Slone Partners Places Kevin Eastwood as Chief Business Officer at Arpeggio Biosciences

PR Newswire

Industry veteran brings more than 25 years of experience in senior leadership roles

SOUTH RIDING, Va., May 29, 2024 /PRNewswire-PRWeb/ -- Slone Partners, a nationwide executive search firm for life sciences and healthcare organizations, has announced the placement of Kevin Eastwood as Chief Business Officer at Arpeggio Biosciences, a preclinical therapeutics company whose technology targets transcriptional dysregulation in disease.

"Kevin Eastwood is a highly accomplished and dynamic business leader with extraordinary passion and vision and a track record of success," said Leslie Loveless, CEO and Managing Partner at Slone Partners.

Eastwood has more than 25 years of experience in senior leadership roles at innovative pharmaceutical and therapeutics companies across the nation. Most recently he served as Executive Vice President, Corporate Development at Plexium, Inc., where he helped secure a $35M series A-2 financing and $102M series B financing and established two multi-target, multi-year drug discovery collaborations, one with Amgen in the oncology disease area and a second with AbbVie in neuroscience. In prior roles, Eastwood served as Vice President, Corporate Development at the California Institute for Biomedical Research and the Scripps Research Institute; Senior Director, Corporate Development, Gilead Sciences, Inc.; and Startup Founder and Senior Vice President, Corporate Development, Effector Therapeutics, Inc.

"Kevin Eastwood is a highly accomplished and dynamic business leader with extraordinary passion and vision and a track record of success," said Leslie Loveless, CEO and Managing Partner at Slone Partners. "He brings a high level of strategic management and business development to the outstanding leadership team at Arpeggio."

"We are thrilled to join forces with Kevin. With over 20 years of experience in business development, at Gilead and platform technology companies like Plexium and Ambrx, Kevin is the ideal person to elevate our functional genomics approach to targeting transcription factors to new heights," said Joey Azofeifa, CEO at Arpeggio.

"I am grateful for the opportunity to join Arpeggio Biosciences to support its mission to transform the discovery of therapeutics that correct dysregulated transcription," Eastwood stated. "Arpeggio's HTS transcriptomics platform GRETA™ provides a novel approach for identifying small molecule transcription modulators, providing an opportunity to drug transcription factors, historically viewed as undruggable targets."

Eastwood earned his B.S. in biology/chemistry from Missouri State University.

ABOUT SLONE PARTNERS

Founded in 2000, Slone Partners is a premier nationwide executive search firm that delivers visionary leaders who build amazing life sciences and healthcare organizations. With a nationwide presence in the most active industry hubs, we specialize in discovering and placing world-class Board, C-Suite leadership, and upper management talent with experience, conviction, and cultural competence in emerging and well-established companies. Our portfolio of executive search and advisory services includes customized cultural solutions through strategic planning, education, training, and coaching. Slone Partners proudly holds the designation as a Certified LGBT Business Enterprise™ by the National Gay & Lesbian Chamber of Commerce (NGLCC) and has earned recognition as a Top Executive Search Firm and a Top 20 Diversity and Inclusion Services firm by Manage HR. To learn more about Slone Partners' value proposition and processes, visit https://www.slonepartners.com or call 888.784.3422.

ABOUT ARPEGGIO BIOSCIENCES

Arpeggio Biosciences is drugging transcription factors using AI and rapid RNA-sequencing. Powered by laboratory automation, Arpeggio discovers drugs based on not just a single target, but the entire cellular network. Arpeggio is currently progressing drug programs towards clinical studies in oncology and chronic kidney disease. To learn more, visit http://www.arpeggiobio.com.

Media Contact

Doug Gavel, Doug Gavel Communications, (617) 429-4417, doug.gavel@gmail.com, http://www.douggavel.com

Cision View original content to download multimedia:https://www.prweb.com/releases/slone-partners-places-kevin-eastwood-as-chief-business-officer-at-arpeggio-biosciences-302157157.html

SOURCE Slone Partners



Back to top
| Back to home page
Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News